CHICAGO, June 24 /PRNewswire-FirstCall/ — Allscripts (Nasdaq: MDRX)
announced today that it will report its financial results for the three months
and fiscal year ended May 31, 2009 after the stock market closes on Monday,
July 20, 2009. At 4:30 PM Eastern Daylight Time on the same day, Allscripts
management will host a conference call and webcast to discuss the company’s
earnings and other information.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)
Update on Company Guidance
The company estimates that new order intake for its clinical solutions
during the three months ended May 31, 2009, was approximately $103 million
($27 million of which, or 26%, will be delivered as Software as a Service),
which compares to $82 million during the same three-month period a year ago
($8 million of which, or 10%, represents Software as a Service), representing
26% growth. The company expects its fourth quarter and full-year revenue and
non-GAAP adjusted earnings to be slightly above the previously communicated
guidance in light of the company’s better than expected sales performance in
the quarter.
More Details on the Call
The earnings announcement will be distributed via PR Newswire immediately
after the market closes on the afternoon of July 20, 2009. The press release
also will be available on the company’s website at www.allscripts.com.
To listen to the conference call online, participants may log onto
www.allscripts.com. It is recommended that participants log onto the website
approximately 15 minutes prior to the start of the conference call to download
and install any necessary software. The conference call also can be accessed
by dialing (877) 230-5050 and requesting the Allscripts earnings call.
International callers can access the audio portion of the webcast by dialing
(973) 532-4923 and requesting the Allscripts Investor Presentation. A
Microsoft Windows Media Player web replay will be available four hours after
the conclusion of the call for a period of two weeks at www.allscripts.com or
by calling (800) 642-1687 – or (706) 645-9291 for international callers – ID #
15908941.
(Minimum requirements to listen to the call online are: Microsoft Windows
Media Player software, downloadable free from
http://windowsmedia.com/download/download.asp, an Internet connection, and
speakers or earphones).
Upcoming Investor Presentations
Allscripts will present at the following upcoming investor events:
- August 6, 2009 at the Oppenheimer 2nd Annual Healthcare Information
Technology 1-on-1 Conference, New York - September 9, 2009 at the Thomas Weisel Partners Healthcare Conference,
Boston - September 15, 2009 at the Stifel Nicolaus Health Care Conference,
Baltimore
The presentations may be accessed live or as archived files at
www.allscripts.com under the “Company” menu (click “Investor Relations”). The
Oppenheimer conference appearance does not include a presentation.
About Allscripts
Allscripts uses innovation technology to bring health to healthcare. More
than 150,000 physicians, 700 hospitals and nearly 7,000 post-acute and
homecare organizations utilize Allscripts to improve the health of their
patients and their bottom line. The Company’s award-winning solutions include
electronic health records, electronic prescribing, revenue cycle management,
practice management, document management, medication services, hospital care
management, emergency department information systems and homecare automation.
Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To
learn more, visit www.allscripts.com.
This news release may contain forward-looking statements within the
meaning of the federal securities laws. Statements regarding future events,
developments, the Company’s future performance, as well as management’s
expectations, beliefs, intentions, plans, estimates or projections relating to
the future are forward-looking statements within the meaning of these laws.
These forward-looking statements are subject to a number of risks and
uncertainties, some of which are outlined below. As a result, actual results
may vary materially from those anticipated by the forward-looking statements.
Among the important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements are: the
volume and timing of systems sales and installations; length of sales cycles
and the installation process; the possibility that products will not achieve
or sustain market acceptance; the timing, cost and success or failure of new
product and service introductions, development and product upgrade releases;
competitive pressures including product offerings, pricing and promotional
activities; our ability to establish and maintain strategic relationships;
undetected errors or similar problems in our software products; compliance
with existing laws, regulations and industry initiatives and future changes in
laws or regulations in the healthcare industry; possible regulation of the
Company’s software by the U.S. Food and Drug Administration; the possibility
of product-related liabilities; our ability to attract and retain qualified
personnel; our ability to identify and complete acquisitions, manage our
growth and integrate acquisitions; the ability to recognize the benefits of
the merger with Misys Healthcare Systems, LLC (“MHS”); the integration of MHS
with the Company and the possible disruption of current plans and operations
as a result thereof; maintaining our intellectual property rights and
litigation involving intellectual property rights; risks related to
third-party suppliers; our ability to obtain, use or successfully integrate
third-party licensed technology; breach of our security by third parties; and
the risk factors detailed from time to time in our reports filed with the
Securities and Exchange Commission, including our 2007 Annual Report on Form
10-K available through the Web site maintained by the Securities and Exchange
Commission at www.sec.gov. The Company undertakes no obligation to update
publicly any forward-looking statement, whether as a result of new
information, future events or otherwise.
SOURCE: Allscripts – 06/24/2009
CONTACT: Dan Michelson, Chief Marketing Officer, +1-312-506-1217,
dan.michelson@allscripts.com,
or Todd Stein, Senior Manager/Public Relations,
+1-312-506-1216, todd.stein@allscripts.com,
or William Davis, Chief Financial
Officer, +1-312-506-1211,
bill.davis@allscripts.com,
all of Allscripts
Web Site: https://www.allscripts.com
(MDRX)